Susan Roethke, CRNP, MSN, AOCN, ANP-BC

Susan Roethke joined the nursing staff at Fox Chase in 1983. She is currently a nurse practitioner who works with patients with genitourinary cancers.
Nurse Practitioner
Medical Oncology
Meet other members of the genitourinary cancer treatment team.
Meet other members of the prostate cancer treatment team.
Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111-2497
To make an appointment, call:
215-728-2570.
For general information, call:
1-888-FOX CHASE.
An oncology certified nurse will assist you.
Nursing Education:
Temple University, Philadelphia, Pa., Masters of Science in Nursing, 2000
Certification/Licensure:
Certified Registered Nurse Practitioner (CRNP);
Oncology Certified Nurse (OCN);
Advanced Oncology Certified Nurse (AOCN);
Adult Nurse Practitioner (ANP)
Honors/Awards:
Temple University College of Allied Health Sciences, Saunders Award, 2000;
Friends of the Fox Chase Cancer Center Scholarship, 1999;
Sigma Theta Tau International Honor Society of Nursing, Kappa Chi Chapter, 1999;
1995 Special Contributor Award, Fox Chase Cancer Center, 1995
Clinical Interests/Research:
Professional Organizations:
Oncology Nursing Society;
American Society of Clinical Oncology
Presentations:
Roethke Susan. Abstract: Safety considerations for Temsirolimus (Torisel TM), a novel inhibitor of mammalian target of rapamycin, in the treatment of patients with advanced renal cell carcinoma. Poster presentation at ONS Advanced Practice Nursing Conference, # 23A-2539, 2007;
Overview of major cancers:Prsotate Cancer in Core Curriculum Revirew Course for Oncology Nurses, FCCC Dept of Continuing Nursing educaction. Annually since 2002;
Symptom Management: Case Studies in Treatment of Prostate Cancer With Radiation. Fox Chase Cancer Center 17th Annual Radiation Oncology Conference for Nurses, Therapists, and Dosimetrists, 2008;
Renal Cell Carcinoma: Case Studies, in: Latest Advances in Oncology Care. Oncology Educational Foundation and Elsevier/Mosby's Oncology Report Live, 2006;
Long term issues facing men with prostate and testicular cancers, in: Cancer Care Along the Continuum: Issues Facing Men. Fox Chase Cancer Center Department of Continuing Nursing Education, 2005.
Publications:
Hudes GR, Nathan F, Haas N, Cornfeld M, Giantonio B, Greenberg R, Gomella L, Litwin S, Ross E, Roethke S, McAleer C. Phase II trial of 96-hour paclitaxel plus oral estramustine phosphate in metastatic hormone-refractory prostate cancer. J Clin Oncol. 1997; 15(9): 3156-63;
Roethke SK. Initial assessment and diagnosis. In: Contemporary Issues in Prostate Cancer: A Nursing Perspective (2nd Ed), ed Held-Warmkessel J. Sudbury MA: Jones and Bartlett Publishers, 2006: 79-106.

Print this Page
E-mail This Page